-
'Devastating' waves leave California beach homes on brink of collapse
-
Tom Cruise's 'Digger' tanks, leaving studio with $250 mn hole
-
Meta says its new AI models on par with OpenAI, Anthropic
-
US actress Selma Blair arrested after flight altercation
-
Talarico rejects mental health conspiracy theory after return from flu
-
One dead as Hurricane Simon creeps along Mexico's Pacific coast
-
Brazil presidential candidate Flavio Bolsonaro to visit jailed father
-
Carrick's Man United 'hungry and eager' to fix worst start in decades
-
Brazil's patron saint reappears in polarized election campaign
-
Fury as US federal agents search anti-Trump lawmaker's home
-
US Open champ Zverev to become tennis world number one
-
One goal enough for Flick as Barca enter Galatasaray cauldron
-
Migrant crisis wounds unhealed in Ceuta as Spanish royals visit
-
A7 to unveil a service that will re-invent the international payments market
-
Brazilian judge allows Flavio Bolsonaro to visit jailed father
-
'Status quo' with EU 'not good enough', UK PM says as summit date set
-
France braces for fresh student demonstrations as Macron calls for 'respect'
-
Stolen Renoir paintings found behind wall in France
-
Zelensky doubtful on Russian acceptance of Trump's 'energy ceasefire'
-
French supermarkets suffer refrigerator shutdown after 'unprecedented' cyberattack
-
Federal agents search home of Trump critic Ilhan Omar: government
-
Arsenal lose Hincapie and Zubimendi in freak double blow
-
Pakistan detains hundreds from ex-PM Khan's party as protests falter
-
Saudi says resilience tested, vows response after deadly airport attacks
-
Australia's Smith off field after being struck on helmet
-
Alcaraz exits Shanghai Masters in straight-sets loss
-
UK retains early access to test latest US AI models
-
Pope to enter hospital on Tuesday for lung operation
-
Top NATO commander warns Russia any attack would be 'futile'
-
Renshaw shines again before Australia declaration
-
Stolen Renoir paintings found behind wall in France: prosecutor
-
Atletico's Simeone encourages goalless Alvarez improvement
-
UNHCR sounds alarm on funding crisis
-
FXGLOBE Rebuilds Its Copy Trading and PAMM Business With B2BROKER's B2COPY
-
French supermarket chains say cyberattack forced refrigerator shutdown
-
Nepal rescuers search for missing after flash flood
-
Minister's resignation rocks German coalition
-
Oil rises as Trump comments roil energy markets
-
Hurricane Simon lashes Mexico's Pacific coast, threatens landfall
-
Premier League in limbo as Manchester City soar
-
France schools protest rumbles on as Macron urges 'respect'
-
Zelensky vows to respond as Moscow silent on 'energy ceasefire'
-
Americans Hall and Woodford win economics Nobel for stabilisation models
-
Thousands march in India's capital to demand election chief resign
-
MEXC Brings AI, TradFi and the Future of Trading to Life at TOKEN2049 Singapore
-
African players in Europe: Mbeumo ends goal drought as United draw
-
Italian rice farmer beats heat with biodiversity haven
-
France's high school students plan fresh protests
-
Stocks mixed as oil prices slip after Trump hails 'energy ceasefire'
-
NZ bank in free speech row over 'explicit' sheep memes
Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing
Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions
Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions
JERSEY CITY, NJ / ACCESS Newswire / September 16, 2025 / Apprentice.io, the creator of the first AI-powered manufacturing platform for life sciences, today announced a strategic partnership with Aprecia, the industry leader in pharmaceutical three-dimensional printing (3DP). This collaboration marks a significant step forward in digitally connected drug manufacturing, combining cutting-edge AI technology with breakthrough 3DP innovation in drug delivery.
Through this partnership, Aprecia will implement Apprentice.io's intelligent manufacturing platform at its Ohio facility to accelerate production workflows designed to ensure consistent, reliable execution at scale. The integration will support Aprecia's mission to revolutionize how medications are produced and delivered using advanced additive manufacturing.
Apprentice's cloud-native platform delivers intuitive digital manufacturing capabilities and no-code integration tools that provide flexibility, scalability, and connectivity appropriate for Aprecia's manufacturing model. As Aprecia continues to grow, this technology foundation will enable rapid deployment and seamless scaling across multiple production sites.
"I believe that Aprecia is the next generation of additive manufacturing," said Angelo Stracquatanio, CEO & Co-founder of Apprentice.io. "They are at the absolute forefront of innovation in life sciences. Combined with our AI native approach to manufacturing, I am looking forward to seeing what we can accomplish in the future."
Aprecia's deployment of Apprentice's technology reflects a shared commitment for next level pharmaceutical manufacturing. The collaboration underscores the industry's rapid evolution toward more sophisticated, data-driven manufacturing approaches that can adapt to and scale complex formulation requirements while maintaining the highest quality standards.
"Aprecia is leading the way in pharmaceutical 3D printing, driven by a commitment to transform patient care through innovation, said Kyle Smith, president and chief operating officer at Aprecia. Our partnership with Apprentice.io strengthens that mission, leveraging AI-powered solutions to scale precision drug delivery and redefine what's possible in oral medication. We will continue to integrate cutting-edge technologies that keep us at the forefront and address the evolving needs of patients and caregivers."
About Aprecia
Aprecia has brought significant change to pharmaceutical manufacturing with advanced 3D printing technology, enhancing the speed, flexibility, and precision of oral medication production. Through strategic partnerships, Aprecia can create personalized medicine and accelerate market entry, setting new standards in the industry.
Located in Mason, Ohio, Aprecia's capabilities include pharmaceutical manufacturing, drug product development, engineering innovation, and analytical methods. For over 20 years, Aprecia has led in pharmaceutical additive manufacturing technologies, establishing 3D printing as a viable pharmaceutical manufacturing option and is continuously exploring ways to improve medicine and patient health outcomes. For more information, visit www.aprecia.com.
About Apprentice
Apprentice is the industry's first agentic manufacturing platform built for a world beyond paper and legacy MES. Apprentice unifies MES, LES, automation, and remote collaboration capabilities together in a modern, no-code platform while simultaneously deploying AI Agents to support every step of manufacturing. The AI Agents operate autonomously to amplify human efforts, optimize processes, and scale throughput while reducing costs. The company's technology drives innovation at every stage-from design and creation to simulation, execution, and optimization. For over a decade, we've helped life sciences companies integrate their people, processes, and systems into a single next-gen platform. Today, Apprentice serves all manufacturing sectors fulfilling the vision of what a digital "Apprentice" can be. For more information, visit www.apprentice.io.
Contact Information:
Kristen Kucks
Director of Communications, Marketing
[email protected]
Justin Foreman
[email protected]
SOURCE: Apprentice.io
View the original press release on ACCESS Newswire
O.Brown--AT